134 related articles for article (PubMed ID: 8033629)
21. Administration of low-dose LH induces ovulation and prevents vascular hyperpermeability and vascular endothelial growth factor expression in superovulated rats.
Gómez R; Lima I; Simón C; Pellicer A
Reproduction; 2004 Apr; 127(4):483-9. PubMed ID: 15047939
[TBL] [Abstract][Full Text] [Related]
22. Reproductive hormonal levels in Malay women with superovulatory cycles.
Nwe HH; Abdul Wadood H; Abdullah RB; Arshad H
Med J Malaysia; 1990 Sep; 45(3):244-50. PubMed ID: 2152087
[TBL] [Abstract][Full Text] [Related]
23. The outcome of continued treatment of luteinizing hormone-surged cycles in in vitro fertilization with the use of human menopausal gonadotropin.
Huang KE; Chang SY; Muechler EK; Graham MC
Fertil Steril; 1987 May; 47(5):816-20. PubMed ID: 3106106
[TBL] [Abstract][Full Text] [Related]
24. Minimal precycle testing and ongoing cycle monitoring for in vitro fertilization and fresh pre-embryo transfer do not compromise fertilization, implantation, or ongoing pregnancy rates.
Strawn EY; Roesler M; Rinke M; Aiman EJ
Am J Obstet Gynecol; 2000 Jun; 182(6):1623-8. PubMed ID: 10871488
[TBL] [Abstract][Full Text] [Related]
25. Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles.
Barrenetxea G; Agirregoikoa JA; Jiménez MR; de Larruzea AL; Ganzabal T; Carbonero K
Fertil Steril; 2008 Mar; 89(3):546-53. PubMed ID: 17531989
[TBL] [Abstract][Full Text] [Related]
26. Reducing the dose of human chorionic gonadotropin in high responders does not affect the outcomes of in vitro fertilization.
Schmidt DW; Maier DB; Nulsen JC; Benadiva CA
Fertil Steril; 2004 Oct; 82(4):841-6. PubMed ID: 15482757
[TBL] [Abstract][Full Text] [Related]
27. [Impact of high response of ovary to gonadotropin stimulation on the outcome of in vitro fertilization and embryo transfer or intracytoplasmic sperm injection].
Lin J; Ye B; Zhao J; Zhou Y; Huang X; Zheng J
Zhonghua Fu Chan Ke Za Zhi; 2002 Oct; 37(10):601-3. PubMed ID: 12487934
[TBL] [Abstract][Full Text] [Related]
28. Effects of different amounts of LH on superovulation induction with long-acting GnRH in an IVF program.
Ragni G; De Laurentis L; Perotti L; Serra AD; Vegetti W; Crosignani PG
Int J Fertil Menopausal Stud; 1996; 41(5):466-9. PubMed ID: 8934255
[TBL] [Abstract][Full Text] [Related]
29. Women with ovulatory dysfunction undergoing ovarian stimulation with clomiphene citrate for intrauterine insemination may benefit from administration of human chorionic gonadotropin.
Vlahos NF; Coker L; Lawler C; Zhao Y; Bankowski B; Wallach EE
Fertil Steril; 2005 May; 83(5):1510-6. PubMed ID: 15866592
[TBL] [Abstract][Full Text] [Related]
30. Comparison of buserelin and nafarelin in IVF cycles and in subsequent frozen-thawed embryo transfer cycles.
Simberg N; Tulppala M; Husa LM; Tiitinen A
Acta Obstet Gynecol Scand; 1998 Sep; 77(8):854-9. PubMed ID: 9776601
[TBL] [Abstract][Full Text] [Related]
31. Superovulation with exogenous gonadotropins does not inhibit the luteinizing hormone surge.
Glasier A; Thatcher SS; Wickings EJ; Hillier SG; Baird DT
Fertil Steril; 1988 Jan; 49(1):81-5. PubMed ID: 3121399
[TBL] [Abstract][Full Text] [Related]
32. Elevated day 3 follicle-stimulating hormone/luteinizing hormone ratio >or= 2 is associated with higher rates of cancellation in in vitro fertilization-embryo transfer cycles.
Liu KE; Greenblatt EM
Fertil Steril; 2008 Aug; 90(2):297-301. PubMed ID: 18023434
[TBL] [Abstract][Full Text] [Related]
33. [Effect of concentration of circulating luteinizing hormone in late-follicle phase on the outcome of in vitro fertilization for normogonadotrophic women].
Sun H; Hu Y; Wang B; Chen Q; Zhang N; Chen H; Wang J; Xu Z
Zhonghua Nan Ke Xue; 2004 Dec; 10(12):912-5. PubMed ID: 15638021
[TBL] [Abstract][Full Text] [Related]
34. Clinical effects of ovulation induction with recombinant follicle-stimulating hormone supplemented with recombinant luteinizing hormone or low-dose recombinant human chorionic gonadotropin in the midfollicular phase in microdose cycles in poor responders.
Berkkanoglu M; Isikoglu M; Aydin D; Ozgur K
Fertil Steril; 2007 Sep; 88(3):665-9. PubMed ID: 17292895
[TBL] [Abstract][Full Text] [Related]
35. Exposure to human chorionic gonadotropin during in vitro maturation does not improve the maturation rate and developmental potential of immature oocytes from patients with polycystic ovary syndrome.
Ge HS; Huang XF; Zhang W; Zhao JZ; Lin JJ; Zhou W
Fertil Steril; 2008 Jan; 89(1):98-103. PubMed ID: 17524398
[TBL] [Abstract][Full Text] [Related]
36. The effect of withholding gonadotropin (a coasting period) on the outcome of in vitro fertilization cycles.
Owj M; Tehrani Nejad ESh; Amirchaghmaghi E; Ezabadi Z; Baghestani AR
Eur J Obstet Gynecol Reprod Biol; 2007 Jul; 133(1):81-5. PubMed ID: 17229513
[TBL] [Abstract][Full Text] [Related]
37. In vitro fertilization: determination of follicular maturation for timing of human chorionic gonadotropin administration.
Casper RF; Armstrong DT; Brown SE; Daniel SA; Yuzpe AA; Erskine H
Fertil Steril; 1987 Feb; 47(2):345-9. PubMed ID: 3102289
[TBL] [Abstract][Full Text] [Related]
38. Changes in plasma progesterone concentrations around the time of the luteinizing hormone surge in women superovulated for in vitro fertilization.
Trounson AO; Calabrese R
J Clin Endocrinol Metab; 1984 Dec; 59(6):1075-80. PubMed ID: 6436284
[TBL] [Abstract][Full Text] [Related]
39. A controlled study of human chorionic gonadotrophin induced ovulation versus urinary luteinizing hormone surge for timing of intrauterine insemination.
Martinez AR; Bernadus RE; Voorhorst FJ; Vermeiden JP; Schoemaker J
Hum Reprod; 1991 Oct; 6(9):1247-51. PubMed ID: 1752926
[TBL] [Abstract][Full Text] [Related]
40. Variations in ambient temperature can lead to incorrect prediction of the luteinizing hormone surge using urinary dipsticks (OvuStick).
Robarts P; Braude P
Br J Obstet Gynaecol; 1987 May; 94(5):486-7. PubMed ID: 3580334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
